From: Effect of high-potency statins on HbA1c in patients with or without diabetes mellitus
High-potency statins | Atorvastatin | Pitavastatin | Rosuvastatin | Low-potency statins | |
---|---|---|---|---|---|
With diabetes | |||||
Number of patients | 153 | 47 | 42 | 64 | 22 |
Mean period (days)a | 209 | 166 | 189 | 254 | 231 |
HbA1c (%), mean ± SD | |||||
Before | 7.18 ± 1.37 | 7.03 ± 1.31 | 7.57 ± 1.64 | 7.03 ± 1.17 | 6.95 ± 1.92 |
After | 7.57 ± 1.58 | 7.25 ± 1.21 | 8.11 ± 1.79 | 7.45 ± 1.61 | 7.25 ± 1.29 |
Difference | 0.39 ± 1.27 | 0.21 ± 0.75 | 0.54 ± 1.61 | 0.42 ± 1.32 | 0.30 ± 0.94 |
p-value | 0.0002 | 0.05 | 0.04 | 0.01 | 0.15 |
Without diabetes | |||||
Number of patients | 165 | 49 | 31 | 85 | 10 |
Mean period (days)a | 239 | 212 | 310 | 229 | 236 |
HbA1c (%), mean ± SD | |||||
Before | 5.78 ± 0.38 | 5.76 ± 0.42 | 5.69 ± 0.24 | 5.81 ± 0.41 | 5.80 ± 0.47 |
After | 5.92 ± 0.45 | 5.95 ± 0.45 | 5.90 ± 0.48 | 5.92 ± 0.45 | 6.07 ± 0.58 |
Difference | 0.15 ± 0.31 | 0.19 ± 0.31 | 0.21 ± 0.46 | 0.10 ± 0.22 | 0.27 ± 0.18 |
p-value | <0.0001 | 0.0001 | 0.02 | <0.0001 | 0.001 |
p-valueb | 0.02 | − | − | − | 0.89 |